Connective tissue growth factor-(CTGF, CCN2) - A marker, mediator and therapeutic target for renal fibrosis

171Citations
Citations of this article
82Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Connective tissue growth factor (CTGF, CCN2) is a key mediator of tissue fibrosis. CCN2 plays an important role in the development of glomerular and tubulointerstitial fibrosis in progressive kidney diseases. In this review, we discuss the biology of CCN2 with a focus on the regulation of CCN2 gene, cellular mechanisms of profibrotic CCN2 effects and the current in vivo and in vitro evidence for the role of CCN2 in the development of renal fibrosis. We also discuss the therapeutic potential of targeting CCN2 for the treatment of renal fibrosis. Copyright © 2009 S. Karger AG, Basel.

Author supplied keywords

Cite

CITATION STYLE

APA

Phanish, M. K., Winn, S. K., & Dockrell, M. E. C. (2010, February). Connective tissue growth factor-(CTGF, CCN2) - A marker, mediator and therapeutic target for renal fibrosis. Nephron - Experimental Nephrology. https://doi.org/10.1159/000262316

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free